It is very difficult to use-it is IV (intravenous) only, and causes major side effects, including kidney failure severe enough to require discontinuation, in over 50% of those treated.
The IV infusion itself is difficult and prolonged.
I am interested in the reference to ribavirin, which is used to treat Hepatitis C and is now available in large quaantities both here and overseas.
According to this document, the dosage would be a one-time IV within 48 hours of exposure: 5 mg/kg IV over 1 h. This vastly differentiates smallpox treatment with cidofovir from the treatment of CMV with the same, since treatment of CMV is ongoing for the life of the patient. According to this study, they believe this one-time, one-hour IV dose will significantly attenuate or even avoid infection with smallpox if administered within 48 hrs of infection - certainly worth the difficulty of administration, and certainly worth the risk of renal damage if administered with proper accompanying medications (probenecid)...